COLUMBUS, Ohio–As concerns about Americans’ exposure to a certain group of chemical substances continues to grow, Battelle researchers have added another tool in their suite to help assess and understand occurrence. Known as per- and polyfluoroalkyl substances (PFAS), PFAS are chemicals that have been used for decades in products that repel stains, water, grease, and oil and in firefighting […]
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a collaboration with Debiopharm, a Swiss pharmaceutical company, to deliver a complete clinical and genomic data management solution to support its innovative oncology pipeline, including investigational product programs for Debio 0123 (Selective WEE1 inhibitor), diagnostic molecular screening for […]
Today the ultra-high-throughput genetic sequencer, DNBSEQ-T7, independently developed by Shenzhen’s MGI Tech Co., Ltd. (MGI), was officially delivered to business partners. The first sequencers have arrived at the joint labs of partners such as BGI Tech Solutions Co., Ltd. and WeGene. Pre-delivery user test data showed that T7 performed well according to all indicators. As […]
HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announces that it has joined the European Molecular Biology Laboratory (EMBL) Corporate Partnership Programme, to help expand EMBL’s portfolio of innovative scientific training courses designed for budding young scientists. EMBL is an intergovernmental organization and […]
Strategic agreement utilizes FDA-approved next-generation sequencing Oncomine Dx Target Test to identify RET-altered non-small cell lung cancer and thyroid cancer patients who may be suitable for LOXO-292, Lilly’s RET inhibitor CARLSBAD, Calif. — Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S […]
SAN DIEGO– SGI-DNA, a company dedicated to developing transformative synthetic genomics technologies and revolutionary DNA data storage solutions, has completed a $25 million Series A financing round led by Northpond Ventures, with participation from Oxford Finance and BroadOak Capital Partners. Proceeds of the financing will support the global commercial launch of the industry’s first fully […]
LA JOLLA, Calif. — The Board of Directors of Cardea Bio and the Board of Directors of Nanosens Innovations have each authorized the respective companies to proceed with a proposed business combination. After the closing, Nanosens would become a subsidiary of Cardea, with the Nanosens brand representing a series of products leveraging the CRISPR-Chip technology. The closing […]
OAKLAND, Calif.–Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced […]
Spartan Bioscience, the leader in on-demand DNA testing, today announced that Blaine Fitzgerald, former Vice President of Finance for Shopify, has been named Chief Financial Officer. Spartan has also named former Shopify CFO Russ Jones and healthcare venture capitalist Joel Finlayson as strategic advisors. Additionally, Spartan has hired Steve Edgett as Executive Vice President […]
BOULDER, Colo.–Inscripta, Inc., developer of the first benchtop platform for scalable Digital Genome Engineering, today named Jim Lalonde, Ph.D. to its management team. Dr. Lalonde has spent more than 25 years in research and development leadership, overseeing significant advances in methods for enzyme engineering and directed evolution. He will lead strategic business and portfolio development […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
